The 80th Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Oral Session

Oral Session 2-7B PTCL/NK lymphoma: Treatment (1)

Sat. Oct 13, 2018 10:10 AM - 11:10 AM No.7 (Osaka International Convention Center, 10F 1001)

Chair: Motoko Yamaguchi (Mie University Graduate School of Medicine, Japan)

[OS2-7B-5] Phase III trial of mogamulizumab vs. vorinostat in previously treated cutaneous T-cell lymphoma

Kensei Tobinai1, Makoto Sugaya2, Noriko Fukuhara3, Yoshiki Tokura4 (1.Department of Hematology, National Cancer Center Hospital, Tokyo, Japan, 2.Dermatology, International University of Health and Welfare, Ichikawa, Japan, 3.Department of Hematology and Rheumatology, Tohoku University, Sendai, Japan, 4.Department of Dermatology, Hamamatsu University School of Medicine, Hamamatsu, Japan)

Abstract password authentication.
Password is written on a program and abstract book.

Password